Epica International Announces FDA Clearance for SeeFactor CT3™: A Leap Forward in Diagnostic Imaging
The FDA has granted 510(k) clearance for expanded use of the SeeFactor CT3™, enhancing its diagnostic imaging capabilities.
top of page
News / Press
Press
Search
Jul 23, 20212 min read
The Spark Center to house Epica International’s new HQ, warehousing, assembly facility
Epica International, a leader in cutting-edge mobile medical imaging systems and precision manufacturing robotics, unveiled their new...
180 views
Dec 22, 20201 min read
Happy Holidays from Epica International
2020 has been a year that none of us will ever forget. While the challenges continue to be numerous and extraordinary, 2020 has also been...
130 views
Oct 2, 20193 min read
Epica Announces FDA 510(k) Clearance for its Multi-modality Mobile CT Imaging Platform, SeeFactorCT3
San Clemente, California. Epica International Inc. (Epica), received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
680 views
Sep 6, 20181 min read
$14M Human Funding Round!
Epica International, Inc. Announcement San Clemente, California, USA Epica International Inc., a privately held CT Imaging and Robotics...
183 views
bottom of page